Literature DB >> 11588180

Long-lasting aberrant tubulovesicular membrane inclusions accumulate in developing motoneurons after a sublethal excitotoxic insult: a possible model for neuronal pathology in neurodegenerative disease.

O Tarabal1, J Calderó, J Lladó, R W Oppenheim, J E Esquerda.   

Abstract

We have previously shown that chronic treatment of chick embryos [from embryonic day 5 (E5) to E9] with NMDA rescues spinal cord motoneurons (MNs) from programmed cell death. In this situation, MNs exhibit a reduced vulnerability to acute excitotoxic lesions and downregulate NMDA and AMPA-kainate receptors. Here, we report that this treatment results in long-lasting sublethal structural changes in MNs. In Nissl-stained sections from the spinal cord of NMDA-treated embryos, MNs display an area adjacent to an eccentrically positioned nucleus in which basophilia is excluded. Ultrastructurally, MNs accumulate tubulovesicular structures surrounded by Golgi stacks. Thiamine pyrophosphatase but not acid phosphatase was detected inside the tubulovesicular structures, which are resistant to disruption by brefeldin A or monensin. Immunocytochemistry reveals changes in the content and distribution of calcitonin gene-related peptide, the KDEL receptor, the early endosomal marker EEA1, and the recycling endosome marker Rab11, indicating that a dysfunction in membrane trafficking and protein sorting occurs in these MNs. FM1-43, a marker of the endocytic pathway, strongly accumulates in MNs from isolated spinal cords after chronic NMDA treatment. Changes in the distribution of cystatin C and presenilin-1 and an accumulation of amyloid precursor protein and beta-amyloid product were also observed in NMDA-treated MNs. None of these alterations involve an interruption of MN-target (muscle) connections, as detected by the retrograde tracing of MNs with cholera toxin B subunit. These results demonstrate that chronic NMDA treatment induces severe changes in the motoneuronal endomembrane system that may be related to some neuropathological alterations described in human MN disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11588180      PMCID: PMC6763851     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  50 in total

1.  Fragmentation of the Golgi apparatus of motor neurons in amyotrophic lateral sclerosis.

Authors:  N K Gonatas; A Stieber; Z Mourelatos; Y Chen; J O Gonatas; S H Appel; A P Hays; W F Hickey; J J Hauw
Journal:  Am J Pathol       Date:  1992-03       Impact factor: 4.307

2.  Opposing effects of excitatory amino acids on chick embryo spinal cord motoneurons: excitotoxic degeneration or prevention of programmed cell death.

Authors:  J Lladó; J Calderó; J Ribera; O Tarabal; R W Oppenheim; J E Esquerda
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  Mitochondrial control of acute glutamate excitotoxicity in cultured cerebellar granule cells.

Authors:  R F Castilho; O Hansson; M W Ward; S L Budd; D G Nicholls
Journal:  J Neurosci       Date:  1998-12-15       Impact factor: 6.167

Review 4.  Cytoskeletal proteins and Golgi dynamics.

Authors:  J Lippincott-Schwartz
Journal:  Curr Opin Cell Biol       Date:  1998-02       Impact factor: 8.382

5.  Endocytosis and autophagy in dying neurons: an ultrastructural study in chick embryos.

Authors:  J P Hornung; H Koppel; P G Clarke
Journal:  J Comp Neurol       Date:  1989-05-15       Impact factor: 3.215

6.  Ultrastructural study of Bunina bodies in the anterior horn neurons of patients with amyotrophic lateral sclerosis.

Authors:  S Sasaki; S Maruyama
Journal:  Neurosci Lett       Date:  1993-05-14       Impact factor: 3.046

7.  Programmed cell death of developing mammalian neurons after genetic deletion of caspases.

Authors:  R W Oppenheim; R A Flavell; S Vinsant; D Prevette; C Y Kuan; P Rakic
Journal:  J Neurosci       Date:  2001-07-01       Impact factor: 6.167

8.  Role of NMDA and non-NMDA ionotropic glutamate receptors in traumatic spinal cord axonal injury.

Authors:  S K Agrawal; M G Fehlings
Journal:  J Neurosci       Date:  1997-02-01       Impact factor: 6.167

9.  Effects of excitatory amino acids on neuromuscular development in the chick embryo.

Authors:  J Calderó; D Ciutat; J Lladó; E Castán; R W Oppenheim; J E Esquerda
Journal:  J Comp Neurol       Date:  1997-10-13       Impact factor: 3.215

10.  GS28, a 28-kilodalton Golgi SNARE that participates in ER-Golgi transport.

Authors:  V N Subramaniam; F Peter; R Philp; S H Wong; W Hong
Journal:  Science       Date:  1996-05-24       Impact factor: 47.728

View more
  4 in total

Review 1.  Motor neuron trophic factors: therapeutic use in ALS?

Authors:  Thomas W Gould; Ronald W Oppenheim
Journal:  Brain Res Rev       Date:  2010-10-21

Review 2.  Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis.

Authors:  Stacey A Sakowski; Adam D Schuyler; Eva L Feldman
Journal:  Amyotroph Lateral Scler       Date:  2009-04

3.  Neural cell adhesion molecule promotes accumulation of TGN organelles at sites of neuron-to-neuron contacts.

Authors:  Vladimir Sytnyk; Iryna Leshchyns'ka; Markus Delling; Galina Dityateva; Alexander Dityatev; Melitta Schachner
Journal:  J Cell Biol       Date:  2002-11-18       Impact factor: 10.539

4.  The Y172 Monoclonal Antibody Against p-c-Jun (Ser63) Is a Marker of the Postsynaptic Compartment of C-Type Cholinergic Afferent Synapses on Motoneurons.

Authors:  Alaó Gatius; Olga Tarabal; Paula Cayuela; Anna Casanovas; Lídia Piedrafita; Sara Salvany; Sara Hernández; Rosa M Soler; Josep E Esquerda; Jordi Calderó
Journal:  Front Cell Neurosci       Date:  2020-01-24       Impact factor: 5.505

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.